Together, these data indicate that TLR2 signaling is intact in HNSCC cells and that activation of TLR2 results in the enhanced activation of the NF-κB and MAPK pathways, both of which have previously been shown to be associated with a survival and growth advantage in this malignancy [41, 42]. The gene discussed is TLR2; the disease is head and neck squamous cell carcinoma.